Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

Although C̄l-inhibitor (C̄l-INH) and α(2)-macroglobulin (α(2)M) have been reported as the major inhibitors of plasma kallikrein in normal plasma, there is little quantitative support for this conclusion. Thus, we studied the inactivation of purified kallikrein in normal plasma, as well as in plasma...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Schapira, Marc, Scott, Cheryl F., Colman, Robert W.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 1982
Aiheet:	Articles
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6173399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110470
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!